HIV and Stage 3 (AIDS) Classifications Data through December 2021 Provided for the Ryan White HIV/AIDS Program, for Fiscal Year 2023: Tables

Print
Related Pages
All Tables
Report Contents
Table 1. Reported stage 3 (AIDS) classifications and persons reported living with diagnosed HIV infection ever classified as stage 3 (AIDS), by area of residence, 2017–2021, and as of December 2021—eligible metropolitan areas and transitional grant areas for the Ryan White HIV/AIDS Program
Reported stage 3 (AIDS) classifications
2017–2021		 Persons reported living with diagnosed HIV infection ever classified as stage 3 (AIDS) (as of December 2021)
Area of residence No. No.
Eligible metropolitan areas (EMAs)
Atlanta-Sandy Springs-Marietta, Georgia 3,928 18,100
Baltimore, Maryland 1,232 9,510
Boston-Brockton-Nashua, Massachusetts-New Hampshire 1,181 9,913
Chicago, Illinois 2,564 15,839
Dallas, Texas 2,296 11,742
Detroit, Michigan 1,018 5,719
Fort Lauderdale, Florida 1,461 9,397
Houston, Texas 2,910 15,554
Los Angeles-Long Beach, California 3,655 28,150
Miami, Florida 2,139 14,633
Nassau-Suffolk, New York 511 3,527
New Haven-Bridgeport-Danbury-Waterbury, Connecticut 348 3,797
New Orleans, Louisiana 712 4,608
New York, New York 5,306 59,206
Newark, New Jersey 910 6,810
Orlando, Florida 1,283 6,275
Philadelphia, Pennsylvania-New Jersey 1,554 13,516
Phoenix-Mesa, Arizona 1,111 5,408
San Diego, California 779 7,398
San Francisco, California 682 10,215
San Juan-Bayamon, Puerto Rico 717 6,066
Tampa-St. Petersburg-Clearwater, Florida 1,322 6,610
Washington, DC-Maryland-Virginia-West Virginia 2,568 19,333
West Palm Beach-Boca Raton, Florida 610 4,810
Transitional grant areas (TGAs)
Austin-San Marcos, Texas 504 3,304
Baton Rouge, Louisiana 474 2,707
Bergen-Passaic, New Jersey 279 2,373
Charlotte-Gastonia-Concord, North Carolina-South Carolina 537 3,104
Cleveland-Lorain-Elyria, Ohio 571 2,678
Columbus, Ohio 573 2,602
Denver, Colorado 636 4,055
Fort Worth-Arlington, Texas 661 2,989
Hartford, Connecticut 206 2,154
Indianapolis, Indiana 531 2,777
Jacksonville, Florida 755 3,897
Jersey City, New Jersey 356 2,850
Kansas City, Missouri-Kansas 427 2,889
Las Vegas, Nevada-Arizona 926 3,873
Memphis, Tennessee-Mississippi-Arkansas 792 3,723
Middlesex-Somerset-Hunterdon, New Jersey 213 1,654
Minneapolis-St. Paul, Minnesota-Wisconsin 515 3,302
Nashville-Davidson-Murfreesboro, Tennessee 422 2,599
Norfolk-Virginia Beach-Newport News, Virginia 673 2,895
Oakland, California 545 5,037
Orange County, California 584 4,105
Portland-Vancouver, Oregon-Washington 320 2,745
Riverside-San Bernardino, California 1,088 5,467
Sacramento, California 434 2,213
St. Louis, Missouri-Illinois 623 3,695
San Antonio, Texas 689 3,493
San Jose, California 243 2,344
Seattle-Bellevue-Everett, Washington 566 4,575

Note. See Commentary for definition of eligible metropolitan areas (EMAs) and transitional grant areas (TGAs).

Table 2. Reported stage 3 (AIDS) classifications and persons reported living with diagnosed HIV infection ever classified as stage 3 (AIDS), by area of residence, 2017–2021, and as of December 2021—emerging communities for the Ryan White HIV/AIDS Program
Reported stage 3 (AIDS) classifications
2017–2021		 Persons reported living with diagnosed HIV infection ever classified as stage 3 (AIDS) (as of December 2021)
Emerging communities (ECs) No. No.
Albany-Schenectady-Troy, New York 155 1,090
Augusta-Richmond County, Georgia-South Carolina 331 1,227
Bakersfield, California 304 1,271
Birmingham-Hoover, Alabama 366 1,686
Buffalo-Niagara Falls, New York 187 1,205
Charleston-North Charleston, South Carolina 241 1,384
Cincinnati-Middletown, Ohio-Kentucky-Indiana 582 2,259
Columbia, South Carolina 404 2,520
Jackson, Mississippi 329 1,688
Lakeland, Florida 252 1,217
Louisville, Kentucky-Indiana 392 1,766
Milwaukee-Waukesha-West Allis, Wisconsin 257 1,625
North Port-Bradenton-Sarasota, Florida* 191 1,062
Oklahoma City, Oklahoma 386 1,465
Philadelphia, Pennsylvania-New Jersey-Delaware-Maryland—Wilmington Division 209 1,428
Pittsburgh, Pennsylvania 282 1,895
Port St. Lucie-Fort Pierce, Florida 146 1,339
Providence-New Bedford-Fall River, Rhode Island-Massachusetts 145 1,367
Raleigh-Cary, North Carolina 349 1,898
Richmond, Virginia 514 2,205
Rochester, New York 177 1,494

Note. See Commentary for definition of emerging communities (ECs).
*This MSA was formerly named Bradenton-Sarasota-Venice, Florida, but the counties delineating the metropolitan statistical area have not changed.

Table 3. Reported number of persons living with diagnosed HIV infection non-stage 3 (AIDS), infection ever classified as stage 3 (AIDS), and total, by area of residence, as of December 2021—United States and dependent areas for the Ryan White HIV/AIDS Program
  HIV infection non-stage 3 (AIDS) HIV infection ever classified as stage 3 (AIDS) Total
Area of residence No. No. No.
Alabama 8,467 5,933 14,400
Alaska 368 399 767
Arizona 9,568 7,222 16,790
Arkansas 3,503 2,743 6,246
California 66,413 73,972 140,385
Colorado 7,449 5,437 12,886
Connecticut 4,155 6,510 10,665
Delaware 1,342 1,952 3,294
District of Columbia 6,614 8,242 14,856
Florida 58,287 59,057 117,344
Georgia 27,417 26,688 54,105
Hawaii 1,191 1,359 2,550
Idaho 521 486 1,007
Illinois 19,791 18,646 38,437
Indiana 6,283 5,665 11,948
Iowa 1,305 1,343 2,648
Kansas 1,817 1,772 3,589
Kentucky 4,171 3,552 7,723
Louisiana 11,793 11,190 22,983
Maine 638 675 1,313
Maryland 15,701 17,236 32,937
Massachusetts 9,471 11,035 20,506
Michigan 9,365 8,586 17,951
Minnesota 4,924 3,832 8,756
Mississippi 5,579 4,854 10,433
Missouri 7,022 6,635 13,657
Montana 259 254 513
Nebraska 1,147 1,086 2,233
Nevada 5,474 4,351 9,825
New Hampshire 643 620 1,263
New Jersey 18,917 18,702 37,619
New Mexico 1,778 1,727 3,505
New York 53,725 71,733 125,458
North Carolina 18,906 13,061 31,967
North Dakota 271 188 459
Ohio 12,913 10,652 23,565
Oklahoma 3,756 2,927 6,683
Oregon 3,004 3,525 6,529
Pennsylvania 16,638 18,968 35,606
Rhode Island 1,152 1,390 2,542
South Carolina 8,737 9,409 18,146
South Dakota 376 285 661
Tennessee 10,338 8,676 19,014
Texas 50,689 47,692 98,381
Utah 1,703 1,543 3,246
Vermont 234 277 511
Virginia 13,452 11,200 24,652
Washington 6,779 6,872 13,651
West Virginia 1,101 976 2,077
Wisconsin 3,475 2,938 6,413
Wyoming 176 167 343
American Samoa 0 0 0
Federated States of Micronesia* 0 0 0
Guam 71 42 113
Marshall Islands* 0 1 1
Northern Mariana Islands 5 10 15
Palau 5 4 9
Puerto Rico 8,536 9,688 18,224
U.S. Virgin Islands 269 346 615

Note. The number of cases shown in the Total column was used by the Health Resources and Services Administration in FY2023 funding calculations.
*See Technical Notes regarding data reported for these jurisdictions.

Table 4. Reported number of persons living with diagnosed HIV infection non-stage 3 (AIDS), infection ever classified as stage 3 (AIDS), and total, by area of residence, as of December 2021—eligible metropolitan areas and transitional grant areas for the Ryan White HIV/AIDS Program
  HIV non-stage 3 (AIDS) HIV infection ever classified as stage 3 (AIDS) Total
Area of residence No. No. No.
Eligible metropolitan areas (EMAs)
Atlanta-Sandy Springs-Marietta, Georgia 18,112 18,100 36,212
Baltimore, Maryland 8,445 9,510 17,955
Boston-Brockton-Nashua, Massachusetts-New Hampshire 8,523 9,913 18,436
Chicago, Illinois 16,950 15,839 32,789
Dallas, Texas 12,382 11,742 24,124
Detroit, Michigan 6,041 5,719 11,760
Fort Lauderdale, Florida 9,743 9,397 19,140
Houston, Texas 15,733 15,554 31,287
Los Angeles-Long Beach, California 26,318 28,150 54,468
Miami, Florida 16,860 14,633 31,493
Nassau-Suffolk, New York 2,789 3,527 6,316
New Haven-Bridgeport-Danbury-Waterbury, Connecticut 2,363 3,797 6,160
New Orleans, Louisiana 4,537 4,608 9,145
New York, New York 43,530 59,206 102,736
Newark, New Jersey 7,055 6,810 13,865
Orlando, Florida 7,085 6,275 13,360
Philadelphia, Pennsylvania-New Jersey 12,310 13,516 25,826
Phoenix-Mesa, Arizona 7,441 5,408 12,849
San Diego, California 6,944 7,398 14,342
San Francisco, California 7,338 10,215 17,553
San Juan-Bayamon, Puerto Rico 5,728 6,066 11,794
Tampa-St. Petersburg-Clearwater, Florida 6,236 6,610 12,846
Washington, DC-Maryland-Virginia-West Virginia 17,384 19,333 36,717
West Palm Beach-Boca Raton, Florida 3,598 4,810 8,408
Transitional grant areas (TGAs)
Austin-San Marcos, Texas 3,436 3,304 6,740
Baton Rouge, Louisiana 2,798 2,707 5,505
Bergen-Passaic, New Jersey 2,245 2,373 4,618
Charlotte-Gastonia-Concord, North Carolina-South Carolina 5,032 3,104 8,136
Cleveland-Lorain-Elyria, Ohio 3,226 2,678 5,904
Columbus, Ohio 3,530 2,602 6,132
Denver, Colorado 5,660 4,055 9,715
Fort Worth-Arlington, Texas 3,519 2,989 6,508
Hartford, Connecticut 1,393 2,154 3,547
Indianapolis, Indiana 3,126 2,777 5,903
Jacksonville, Florida 3,581 3,897 7,478
Jersey City, New Jersey 2,808 2,850 5,658
Kansas City, Missouri-Kansas 2,669 2,889 5,558
Las Vegas, Nevada-Arizona 4,913 3,873 8,786
Memphis, Tennessee-Mississippi-Arkansas 4,608 3,723 8,331
Middlesex-Somerset-Hunterdon, New Jersey 1,676 1,654 3,330
Minneapolis-St. Paul, Minnesota-Wisconsin 4,288 3,302 7,590
Nashville-Davidson-Murfreesboro, Tennessee 3,146 2,599 5,745
Norfolk-Virginia Beach-Newport News, Virginia 4,376 2,895 7,271
Oakland, California 3,890 5,037 8,927
Orange County, California 4,104 4,105 8,209
Portland-Vancouver, Oregon-Washington 2,525 2,745 5,270
Riverside-San Bernardino, California 5,468 5,467 10,935
Sacramento, California 2,338 2,213 4,551
St. Louis, Missouri-Illinois 4,206 3,695 7,901
San Antonio, Texas 3,905 3,493 7,398
San Jose, California 1,764 2,344 4,108
Seattle-Bellevue-Everett, Washington 4,560 4,575 9,135

Note. The number of cases shown in the Total column was used by the Health Resources and Services Administration in FY2023 funding calculations.
*See Technical Notes regarding data reported for these jurisdictions.

Table 5. Reported number of persons living with diagnosed HIV infection non-stage 3 (AIDS), infection ever classified as stage 3 (AIDS), and total, by area of residence, as of December 2021—emerging communities for the Ryan White HIV/AIDS Program
  HIV infection non-stage 3 (AIDS) HIV infection ever classified as stage 3 (AIDS) Total
Emerging communities (ECs) No. No. No.
Albany-Schenectady-Troy, New York 912 1,090 2,002
Augusta-Richmond County, Georgia-South Carolina 1,207 1,227 2,434
Bakersfield, California 1,317 1,271 2,588
Birmingham-Hoover, Alabama 2,633 1,686 4,319
Buffalo-Niagara Falls, New York 1,310 1,205 2,515
Charleston-North Charleston, South Carolina 1,429 1,384 2,813
Cincinnati-Middletown, Ohio-Kentucky-Indiana 2,580 2,259 4,839
Columbia, South Carolina 2,165 2,520 4,685
Jackson, Mississippi 1,915 1,688 3,603
Lakeland, Florida 1,047 1,217 2,264
Louisville, Kentucky-Indiana 2,294 1,766 4,060
Milwaukee-Waukesha-West Allis, Wisconsin 1,911 1,625 3,536
North Port-Bradenton-Sarasota, Florida* 904 1,062 1,966
Oklahoma City, Oklahoma 1,882 1,465 3,347
Philadelphia, Pennsylvania-New Jersey-Delaware-Maryland—Wilmington Division 981 1,428 2,409
Pittsburgh, Pennsylvania 1,782 1,895 3,677
Port St. Lucie-Fort Pierce, Florida 724 1,339 2,063
Providence-New Bedford-Fall River, Rhode Island-Massachusetts 1,111 1,367 2,478
Raleigh-Cary, North Carolina 2,288 1,898 4,186
Richmond, Virginia 2,823 2,205 5,028
Rochester, New York 1,268 1,494 2,762

Note. See Commentary for definition of emerging communities (ECs).
The number of cases shown in the Total column was used by the Health Resources and Services Administration in FY2023 funding calculations.
*This MSA was formerly named Bradenton-Sarasota-Venice, Florida, but the counties delineating the metropolitan statistical area have not changed.

Top of Page